Featured Post

Latest Gold News

Economic power could shift further East with Hong Kong gold exchange Russian investment bank sees $1,400 gold by end of 2017 Weak CPI...

Tuesday, November 1, 2011

Humana (HUM) (ENDP) (EW) (HFWA) (HMSY) (HTWR) Ratings Reiterated

Humana (NYSE: HUM), Endo Pharmaceuticals (NASDAQ: ENDP), Edwards Lifesciences (NYSE: EW), Heritage Financial Co. (NASDAQ: HFWA), Hms Holdings Corporation (NASDAQ: HMSY) and HeartWare (NASDAQ: HTWR) had ratings on them reiterated by analysts.

Citigroup (NYSE:C) reiterated its "Buy" rating on Humana (HUM). They have a price target of $85.00 on the company.

Citigroup reiterated its "Buy" rating on Endo Pharmaceuticals (ENDP). They have a price target of $48.00 on the company.

Morgan Keegan reiterated its "Overweight" rating on Edwards Lifesciences (EW).

Wunderlich reiterated its "Buy" rating on Heritage Financial Co. (HFWA).

Morgan Stanley (NYSE:MS) reiterated its "Equal Weight" rating on Hms Holdings Corporation (HMSY).

Piper Jaffray reiterated its "Neutral" rating on HeartWare (HTWR).

No comments: